OTC
Strength
8.8 mg/5mL
Manufacturer
Llorens Pharmaceutical International DivisionNDC
54859080808
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SENNOSIDESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
5/1/2019
Related Drugs
Same classification
No related drugs found.